MILLER STRATEGIES, LLC

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · represents biopharmaceutical research companies

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $60,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Medicare/Medicaid

Medicare and healthcare policy issues as they relate to drug pricing, CMMI, and Medicare Part D; including rebate system reforms

Foreign Relations

Issues related to COINS Act implementation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.